CD4 and neoplasm: In contrast, TA-specific interleukin (IL)-4-producing CD4+ T helper (Th2) cells evolved as a negative prognostic marker within the tumor microenvironment (TME) as they promote tumor growth by enhancing angiogenesis and inhibiting cell-mediated immunity 24-26.